Management of Tramadol Withdrawal

Understanding Tramadol and Its Withdrawal Risk

Tramadol is a centrally acting analgesic with dual mechanism of action: weak μ-opioid receptor agonist activity and inhibition of serotonin and norepinephrine reuptake, according to the Mayo Clinic Proceedings 2, 3
All patients treated with long-term tramadol therapy develop physical dependence, making gradual tapering essential when discontinuing treatment, as stated by the Mayo Clinic Proceedings 2

The American College of Physicians recommends that for most patients, begin with an initial reduction of 10% or less of the original dose per week, as suggested by the Mayo Clinic Proceedings 1
For patients on prolonged tramadol therapy, consider slower tapers of 10% per month or less, according to the Mayo Clinic Proceedings 1
Adjust the tapering schedule based on individual response and withdrawal symptom severity, as recommended by the Mayo Clinic Proceedings 1

The American Academy of Emergency Medicine suggests using adjuvant medications liberally to manage specific withdrawal symptoms, such as clonidine or lofexidine for anxiety and autonomic symptoms, as stated in the Annals of Emergency Medicine 5
For nausea and vomiting, the Society of Critical Care Medicine recommends antiemetic medications should be prescribed as needed, according to the Intensive Care Medicine journal 6
For pain symptoms, the American College of Physicians recommends non-opioid analgesics such as NSAIDs or acetaminophen may be helpful, as suggested by the Mayo Clinic Proceedings 7

The American Academy of Emergency Medicine recommends that when initiating buprenorphine, discontinue all opioids the night before initiation, wait for mild withdrawal symptoms to appear, and start with 2-4 mg, repeated at 2-hour intervals if well tolerated, until withdrawal symptoms resolve, as stated in the Annals of Emergency Medicine 5

The American Geriatrics Society recommends that older patients and those with renal or hepatic dysfunction are more prone to drug accumulation and should be maintained on lower doses during tapering, according to the Mayo Clinic Proceedings 2, 3
The American College of Physicians warns of the risk of serotonin syndrome when tramadol is used concurrently with SSRIs, SNRIs, or MAOIs, as stated in the Praxis Medical Insights 4

The American College of Physicians recommends monitoring for protracted withdrawal symptoms that may persist for months, including dysphoria, irritability, insomnia, and anhedonia, as suggested by the Mayo Clinic Proceedings 1
The American Academy of Family Physicians recommends providing patient education about expected withdrawal symptoms and their management, according to the Mayo Clinic Proceedings 1